Outliers of bone metabolic diseases.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.metabol.2017.09.009PMID 28987276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Juvenile Paget disease

  2020cited by this paper
• Hypophosphatasia.

  2018cited by this paper
• Biology and treatment of myeloma related bone disease.

  2017cited by this paper
• Bone disease in primary hyperparathyroidism.

  2017cited by this paper
• Bone metabolism in anorexia nervosa and hypothalamic amenorrhea.

  2017cited by this paper
• Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.

  2017cited by this paper
• Osteogenesis imperfecta - A clinical update.

  2017cited by this paper
• Bone disease in β thalassemia patients: past, present and future perspectives.

  2017cited by this paper
• Denosumab for the treatment of adult multisystem Langerhans cell histiocytosis.

  2017cited by this paper
• Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.

  2017cited by this paper
• Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.

  2017cited by this paper
• Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry

  2017cited by this paper
• Juvenile Paget disease.

  2017cited by this paper
• Paget's disease of bone.

  2017cited by this paper
• MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation.

  2017cited by this paper
• Treating rare disorders: time to act on unfair prices.

  2017cited by this paper
• Value of rare low bone mass diseases for osteoporosis genetics.

  2016cited by this paper
• Romosozumab Treatment in Postmenopausal Women with Osteoporosis.

  2016cited by this paper
• From disease to treatment: from rare skeletal disorders to treatments for osteoporosis

  2016cited by this paper
• Nosology and classification of genetic skeletal disorders: 2015 revision

  2015cited by this paper
• Taxonomy of rare genetic metabolic bone disorders

  2015cited by this paper
• Use of Targeted Exome Sequencing for Molecular Diagnosis of Skeletal Disorders

  2015cited by this paper
• Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene).

  2014cited by this paper
• Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

  2012cited by this paper
• Idiopathic Hyperphosphatasia and TNFRSF11B Mutations: Relationships Between Phenotype and Genotype

  2003cited by this paper
• Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.

  2003cited by this paper

• Progress in oral biomaterials for the treatment of metabolic bone diseases

  2025cites this paper
• Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density

  2019cites this paper
• Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.

  2018cites this paper